Bayer

This study tested whether adding darolutamide to standard hormone therapy and chemotherapy helps men with metastatic prostate cancer that still responds to hormones. Over 1,300 men took part. The goal was to see if the combination improved overall survival. Results showed that da…

This study tested a drug called Radium-223 in 921 men with advanced prostate cancer that no longer responds to hormone therapy and has spread to the bones. The goal was to see if it could help them live longer and slow down the disease. Participants received either the drug or a …

This study tested whether adding the drug copanlisib to standard rituximab therapy helps people with relapsed indolent B-cell non-Hodgkin's lymphoma live longer without their cancer getting worse. About 458 adults who had already received at least one prior treatment took part. T…

This study tested a drug called elinzanetant for treating hot flashes in 628 women who have gone through menopause. The drug works by blocking a protein that may trigger hot flashes. Participants took either the drug or a placebo daily for 52 weeks and recorded their hot flashes …

This study looked at data from 348 people with type 2 diabetes in Germany who use the myTherapy app. The goal was to see how many have elevated levels of albumin in their urine, which is an early sign of kidney disease. Researchers tracked these levels over about a year to unders…

This study looks at medical records of children under 18 in Japan who were prescribed rivaroxaban or warfarin for blood clots. Researchers want to see how often serious bleeding happens with each drug in everyday care. No extra tests or visits are needed—only existing health data…

This study observed over 6,500 Chinese adults with chronic kidney disease and type 2 diabetes who started taking the drug finerenone. Researchers looked at patient health records to understand how the drug is used in real life, including its effects on kidney function and potassi…

This study looked at health insurance records of over 640,000 people in the US who had acute respiratory distress syndrome (ARDS) and were treated in the ICU. Researchers wanted to find out what new health problems—physical, mental, or emotional—people face after leaving the ICU,…